AU2006248981B2 - Use of adamantyl methoxydi phenyl propenoic acid for the treatment of acne - Google Patents

Use of adamantyl methoxydi phenyl propenoic acid for the treatment of acne Download PDF

Info

Publication number
AU2006248981B2
AU2006248981B2 AU2006248981A AU2006248981A AU2006248981B2 AU 2006248981 B2 AU2006248981 B2 AU 2006248981B2 AU 2006248981 A AU2006248981 A AU 2006248981A AU 2006248981 A AU2006248981 A AU 2006248981A AU 2006248981 B2 AU2006248981 B2 AU 2006248981B2
Authority
AU
Australia
Prior art keywords
acne
mice
treatment
comedones
lecithin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2006248981A
Other languages
English (en)
Other versions
AU2006248981A1 (en
Inventor
Claudio Pisano
Loredana Vesci
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Sigma Tau Industrie Farmaceutiche Riunite SpA
Publication of AU2006248981A1 publication Critical patent/AU2006248981A1/en
Application granted granted Critical
Publication of AU2006248981B2 publication Critical patent/AU2006248981B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
AU2006248981A 2005-05-20 2006-05-05 Use of adamantyl methoxydi phenyl propenoic acid for the treatment of acne Ceased AU2006248981B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT000248A ITRM20050248A1 (it) 2005-05-20 2005-05-20 Uso acido adamantil metossidifenil propenoico per il trattamento di patologie cutanee.
ITRM2005A000248 2005-05-20
PCT/EP2006/062088 WO2006122883A1 (en) 2005-05-20 2006-05-05 Use of adamantyl methoxydi phenyl propenoic acid for the treatment of acne

Publications (2)

Publication Number Publication Date
AU2006248981A1 AU2006248981A1 (en) 2006-11-23
AU2006248981B2 true AU2006248981B2 (en) 2011-06-02

Family

ID=36646157

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2006248981A Ceased AU2006248981B2 (en) 2005-05-20 2006-05-05 Use of adamantyl methoxydi phenyl propenoic acid for the treatment of acne

Country Status (13)

Country Link
US (1) US7635719B2 (enExample)
EP (1) EP1890671B1 (enExample)
JP (1) JP5072833B2 (enExample)
KR (1) KR101307910B1 (enExample)
CN (1) CN101180028B (enExample)
AR (1) AR054361A1 (enExample)
AU (1) AU2006248981B2 (enExample)
BR (1) BRPI0611289A2 (enExample)
CA (1) CA2606567A1 (enExample)
IT (1) ITRM20050248A1 (enExample)
MX (1) MX2007014222A (enExample)
TW (1) TWI365753B (enExample)
WO (1) WO2006122883A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5109383B2 (ja) * 2007-01-31 2012-12-26 大正製薬株式会社 アダパレン含有外用剤組成物
JP2009137874A (ja) * 2007-12-05 2009-06-25 Authele:Kk ビタミンＣ（Ａｓｃｏｒｂｉｃａｃｉｄ）を含有するレシチンゲルおよびその製造方法
TW201031402A (en) * 2008-12-24 2010-09-01 Sigma Tau Ind Farmaceuti New retinoid derivatives endowed with cytotoxic and/or antiangiogenic properties
EP3301085A1 (en) * 2016-09-29 2018-04-04 Biogem S.Ca.R.L. Retinoid derivatives with antitumor activity

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003011808A1 (en) * 2001-07-31 2003-02-13 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Retinoid derivatives with antiangiogenic, antitumoral and proapoptotic activities

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6071923A (en) * 1994-09-16 2000-06-06 Bar-Ilan University Retinoyloxy aryl-substituted alkylene butyrates useful for the treatment of cancer and other proliferative diseases
FR2752734B1 (fr) * 1996-09-02 1998-11-06 Cird Galderma Utilisation de retinoides pour la preparation d'un medicament destine a traiter les affections liees a une surexpression de vegf
US5994330A (en) * 1998-11-09 1999-11-30 El Khoury; Georges F. Topical application of muscarinic agents such as neostigmine for treatment of acne and other inflammatory conditions
WO2003075908A1 (en) * 2002-03-12 2003-09-18 Galderma Research & Development, S.N.C. Use of adapalene for the treatment of dermatological disorders

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003011808A1 (en) * 2001-07-31 2003-02-13 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Retinoid derivatives with antiangiogenic, antitumoral and proapoptotic activities

Also Published As

Publication number Publication date
AU2006248981A1 (en) 2006-11-23
WO2006122883A1 (en) 2006-11-23
TW200716192A (en) 2007-05-01
KR20080016573A (ko) 2008-02-21
US20080153916A1 (en) 2008-06-26
MX2007014222A (es) 2008-02-07
CN101180028A (zh) 2008-05-14
US7635719B2 (en) 2009-12-22
WO2006122883A9 (en) 2012-10-04
ITRM20050248A1 (it) 2006-11-21
HK1117737A1 (en) 2009-01-23
EP1890671A1 (en) 2008-02-27
KR101307910B1 (ko) 2013-09-16
CN101180028B (zh) 2010-12-08
AR054361A1 (es) 2007-06-20
JP2008540603A (ja) 2008-11-20
BRPI0611289A2 (pt) 2010-08-31
CA2606567A1 (en) 2006-11-23
JP5072833B2 (ja) 2012-11-14
EP1890671B1 (en) 2014-03-05
TWI365753B (en) 2012-06-11

Similar Documents

Publication Publication Date Title
Vasam et al. Acne vulgaris: A review of the pathophysiology, treatment, and recent nanotechnology based advances
JP6818792B2 (ja) メラニン改変組成物および使用方法
HK59493A (en) Dermatological, pharmaceutical or cosmetic composition consisting of hydrated lipid lamellar phases or liposomes and containing retinoids or analogues such as carotenoids
Rigopoulos et al. Comparison of topical retinoids in the treatment of acne
JP2022511270A (ja) シロリムス含有組成物
HK1223297A1 (en) Topical retinoid solutions
AU2006248981B2 (en) Use of adamantyl methoxydi phenyl propenoic acid for the treatment of acne
Runnsjö et al. A novel microparticle based formulation for topical delivery of FOL-005, a small peptide
Aggnihotri Formulation and development of botanicals-based herbal serum
RU2450836C1 (ru) Комбинированная мазевая композиция для уменьшения интенсивности локальной гиперпигментации кожи
Saif et al. Formulation and Evaluation of Salicylic Acid and Kojic Acid as Gel Novel Drug Delivery Systems for Treatment of Acne and Whitening Skin Effect
Guleria et al. Decoding acne vulgaris: Insights into pathogenesis, treatment modalities, diagnosis and recent advancements
WO2019044670A1 (ja) ざ瘡様疾患を治療又は予防するための皮膚外用組成物
HK1117737B (en) Use of adamantyl methoxydi phenyl propenoic acid for the treatment of acne
WO2021076722A1 (en) Compositions and methods of treating acne and photoaging
US10022348B2 (en) Topical solution of isotretinoin
Naudé Formulation, in vitro release and transdermal diffusion of Vitamin A and Zinc for the treatment of acne
Salim Emerging Formulations and Clinical Applications of Topical Salicylic Acid in Acne management
Farah The effect of heat and chemical penetration enhancers on the follicular absorption of topically applied drugs
WO2021189077A1 (en) Methods for treating acne
Cunliffe Vitamin a in Dermatology
White et al. Pharmacology of salicylic acid (SA) in acne vulgaris Otto Mills, PhD, Robert Wood Johnson Medical School, New Brunswick, NJ, United States; Donald Adler, DO, private practice, Doylestown, PA, United States; Robert Verdicchio, PhD, Verdi Enterprise, Succasunna, NJ The role of SA is acne treatment is dependent upon several pharmacological actions
Parab et al. DESIGN OF TRAMADOL HYDROCHLORIDE LOADED SOLID LIPID NANOPARTICLES BASED GELS FOR PAIN MANAGEMENT

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired